Eric M. Gordon serves as Executive at Targanta Therapeutics Corp., where they oversee executive responsibilities. Since joining the company, Eric M. Gordon has executed 9 insider transactions totaling $4.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 25, 2009 involved transacting 12,599 shares valued at $0.
Eric M. Gordon currently holds 10,170 shares of Targanta Therapeutics Corp. (TARG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric M. Gordon has been a net buyer of TARG stock. They have purchased $4.0M and sold $0 worth of shares.
Eric M. Gordon's most recent insider trade was on Feb 25, 2009, when they sold 12,599 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 25, 2009 | TARG | $0 | Tender | 505,998 | $N/A | Discretionary |
| Oct 15, 2007 | TARG | $0 | Conversion | 10,170 | $N/A | Discretionary |
| Oct 15, 2007 | TARG | $3.0M | Purchase | 300,000 | $10.00 | Discretionary |
| Oct 15, 2007 | TARG | $975.7K | Purchase | 97,571 | $10.00 | Discretionary |
| Oct 15, 2007 | TARG | $0 | Conversion | 408,427 | $N/A | Discretionary |
| Oct 15, 2007 | TARG | $0 | Conversion | 1,399,311 | $N/A | Discretionary |
| Oct 15, 2007 | TARG | $24.3K | Purchase | 2,429 | $10.00 | Discretionary |